Status:
ACTIVE_NOT_RECRUITING
COVID-19 & Psychiatry: A Retrospective Chart Review
Lead Sponsor:
Northwestern University
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
A retrospective chart review study to determine the effects of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression, and severity.
Detailed Description
The goal of this study would be to study the association between use of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression and severity.
Eligibility Criteria
Inclusion
- \- Individuals with a positive COVID-19 test between March 15 2020 to November 30 2021 at Northwestern Medicine hospitals.
Exclusion
- \-
Key Trial Info
Start Date :
January 12 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2025
Estimated Enrollment :
65000 Patients enrolled
Trial Details
Trial ID
NCT05244096
Start Date
January 12 2022
End Date
March 30 2025
Last Update
April 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwester Clinical Research Program
Chicago, Illinois, United States, 60611